Speaking Engagement

Shifting Tides: A Wall Street Perspective on Biotech Deal-making in the Current Global Climate

BIO CEO & Investor Conference

10 Feb 2020 04:30 p.m. - 05:45 p.m.

New York Marriott Marquis
1535 Broadway
New York, NY 10036

Register


Despite a record number of large deals across the pharmaceutical and biotechnology landscape, market indicators are pointing toward a noticeable shift in the appetite for global deal-making across the industry. As the pool of high-valued assets becomes smaller, will signs point to a drastic increase in smaller deals for larger pharma companies looking to solidify their balance sheets across core therapeutic areas? How does a strong public market with a well-capitalized pool of young biotech targets that don’t need to be forced into an early buyout impact this hypothetical M&A shift? This session will feature experienced voices explaining the public perspective for a potentially active year within pharma and biotech deal-making.

Moderator:

  • Ori Solomon, Partner at Morrison & Foerster 

Panel speakers:

  • Kimberly Nearing, Managing Director, Head of Life Sciences, Cedrus Group; Regional Leader for BayHelix's NY/NJ/PA Chapters
  • Andrew Gitkin, Managing Director and Co-Head of Healthcare Investment Banking, Raymond James
  • E. Eric Tokat, Partner Centerview Partners LLC
  • Philip Ross, Vice Chairman, Healthcare Investment Banking, J.P. Morgan

Close

Feedback

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.